186 related articles for article (PubMed ID: 23929973)
1. Physiology. Lymphatics are in my veins.
Simons M; Eichmann A
Science; 2013 Aug; 341(6146):622-4. PubMed ID: 23929973
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic endothelial cell fate specification in the mammalian embryo: An historical perspective.
Oliver G
Dev Biol; 2022 Feb; 482():44-54. PubMed ID: 34915023
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
[No Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
5. Sox18 induces development of the lymphatic vasculature in mice.
François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
[TBL] [Abstract][Full Text] [Related]
6. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
Mishima K; Watabe T; Saito A; Yoshimatsu Y; Imaizumi N; Masui S; Hirashima M; Morisada T; Oike Y; Araie M; Niwa H; Kubo H; Suda T; Miyazono K
Mol Biol Cell; 2007 Apr; 18(4):1421-9. PubMed ID: 17287396
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic fate specification: an ERK-controlled transcriptional program.
Yu P; Tung JK; Simons M
Microvasc Res; 2014 Nov; 96():10-5. PubMed ID: 25132472
[TBL] [Abstract][Full Text] [Related]
8. HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development.
Gauvrit S; Villasenor A; Strilic B; Kitchen P; Collins MM; Marín-Juez R; Guenther S; Maischein HM; Fukuda N; Canham MA; Brickman JM; Bogue CW; Jayaraman PS; Stainier DYR
Nat Commun; 2018 Jul; 9(1):2704. PubMed ID: 30006544
[TBL] [Abstract][Full Text] [Related]
9. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
[TBL] [Abstract][Full Text] [Related]
10. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
11. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
12. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
[TBL] [Abstract][Full Text] [Related]
14. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
[TBL] [Abstract][Full Text] [Related]
15. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
[TBL] [Abstract][Full Text] [Related]
16. Arap3 is dysregulated in a mouse model of hypotrichosis-lymphedema-telangiectasia and regulates lymphatic vascular development.
Kartopawiro J; Bower NI; Karnezis T; Kazenwadel J; Betterman KL; Lesieur E; Koltowska K; Astin J; Crosier P; Vermeren S; Achen MG; Stacker SA; Smith KA; Harvey NL; François M; Hogan BM
Hum Mol Genet; 2014 Mar; 23(5):1286-97. PubMed ID: 24163130
[TBL] [Abstract][Full Text] [Related]
17. mafba is a downstream transcriptional effector of Vegfc signaling essential for embryonic lymphangiogenesis in zebrafish.
Koltowska K; Paterson S; Bower NI; Baillie GJ; Lagendijk AK; Astin JW; Chen H; Francois M; Crosier PS; Taft RJ; Simons C; Smith KA; Hogan BM
Genes Dev; 2015 Aug; 29(15):1618-30. PubMed ID: 26253536
[TBL] [Abstract][Full Text] [Related]
18. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
19. Endothelial ERK signaling controls lymphatic fate specification.
Deng Y; Atri D; Eichmann A; Simons M
J Clin Invest; 2013 Mar; 123(3):1202-15. PubMed ID: 23391722
[TBL] [Abstract][Full Text] [Related]
20. Divergence of zebrafish and mouse lymphatic cell fate specification pathways.
van Impel A; Zhao Z; Hermkens DM; Roukens MG; Fischer JC; Peterson-Maduro J; Duckers H; Ober EA; Ingham PW; Schulte-Merker S
Development; 2014 Mar; 141(6):1228-38. PubMed ID: 24523456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
